DUS 1833:2017, Baby oils — Specification
Distribution date: 06 January 2021 | Final date for Comment: 14 May 2025
The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1833:2019, Baby oils — Specification; notified in G/TBT/N/UGA/755, G/TBT/N/UGA/755/Add.1 and G/TBT/N/UGA/755/Add.2 was withdrawn on 15 December 2020.
Products Covered: Baby oils.
Regulation Type: Addendum to Regular Notification
DUS 1833:2017, Baby oils — Specification
Distribution date: 06 January 2021 | Final date for Comment: 14 May 2025
The aim of this addendum is to inform WTO Members that the Uganda Standard; US 1833:2019, Baby oils — Specification; notified in G/TBT/N/UGA/755, G/TBT/N/UGA/755/Add.1 and G/TBT/N/UGA/755/Add.2 was withdrawn on 15 December 2020.
Products Covered: Baby oils.
Regulation Type: Addendum to Regular Notification
Asbestos (Part 1: Chrysotile Asbestos); Final Toxic Substances Control Act (TSCA) Risk Evaluation; Notice of Availability
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
Notice - The Environmental Protection Agency (EPA) is announcing the availability of the final Toxic Substances Control Act (TSCA) risk evaluation of Asbestos Part 1 (Chrysotile Asbestos). The purpose of conducting risk evaluations under TSCA is to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use, including an unreasonable risk to a relevant potentially exposed or susceptible subpopulation, without consideration of costs or other nonrisk factors. EPA has determined that specific conditions of use of Chrysotile Asbestos present an unreasonable risk of injury to health. For those conditions of use for which EPA has found an unreasonable risk, EPA must take regulatory action to address that unreasonable risk through risk management measures enumerated in TSCA. EPA has also determined that specific conditions of use do not present unreasonable risk of injury to health or the environment. For those conditions of use for which EPA has found no unreasonable risk to health or the environment, the Agency's determination is a final Agency action and is issued via order in the risk evaluation. EPA is currently developing Part 2 of the TSCA risk evaluation for Asbestos which will evaluate risk of injury to health or the environment for legacy uses and associated disposals of asbestos. The Agency plans to release a draft scope for Part 2 of the risk evaluation for Asbestos for public comment mid-year 2021.
Products Covered: Asbestos (Chrysotile Asbestos), risk evaluation
Regulation Type: Regular notification
Asbestos (Part 1: Chrysotile Asbestos); Final Toxic Substances Control Act (TSCA) Risk Evaluation; Notice of Availability
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
Notice - The Environmental Protection Agency (EPA) is announcing the availability of the final Toxic Substances Control Act (TSCA) risk evaluation of Asbestos Part 1 (Chrysotile Asbestos). The purpose of conducting risk evaluations under TSCA is to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment under the conditions of use, including an unreasonable risk to a relevant potentially exposed or susceptible subpopulation, without consideration of costs or other nonrisk factors. EPA has determined that specific conditions of use of Chrysotile Asbestos present an unreasonable risk of injury to health. For those conditions of use for which EPA has found an unreasonable risk, EPA must take regulatory action to address that unreasonable risk through risk management measures enumerated in TSCA. EPA has also determined that specific conditions of use do not present unreasonable risk of injury to health or the environment. For those conditions of use for which EPA has found no unreasonable risk to health or the environment, the Agency's determination is a final Agency action and is issued via order in the risk evaluation. EPA is currently developing Part 2 of the TSCA risk evaluation for Asbestos which will evaluate risk of injury to health or the environment for legacy uses and associated disposals of asbestos. The Agency plans to release a draft scope for Part 2 of the risk evaluation for Asbestos for public comment mid-year 2021.
Products Covered: Asbestos (Chrysotile Asbestos), risk evaluation
Regulation Type: Regular notification
Standards and Specifications for Foods, Food Additives, Etc. under the Food Sanitation Act (Revision of agricultural chemical residue standards, final rule)
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
The proposed maximum residue limits (MRLs) for Mefentrifluconazole notified in G/SPS/N/JPN/766 (dated 30 July 2020) were adopted and published on 16 November 2020. The specified MRLs are available as below:
Products Covered:
Regulation Type: Addendum to Regular Notification
Standards and Specifications for Foods, Food Additives, Etc. under the Food Sanitation Act (Revision of agricultural chemical residue standards, final rule)
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
The proposed maximum residue limits (MRLs) for Mefentrifluconazole notified in G/SPS/N/JPN/766 (dated 30 July 2020) were adopted and published on 16 November 2020. The specified MRLs are available as below:
Products Covered:
Regulation Type: Addendum to Regular Notification
Standards and Specifications for Foods, Food Additives, Etc. under the Food Sanitation Act (Revision of agricultural chemical residue standards, final rule)
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
The proposed maximum residue limits (MRLs) for Tildipirosin notified in G/SPS/N/JPN/769 (dated 30 July 2020) were adopted and published on 16 November 2020. The specified MRLs are available as below:
Products Covered:
Regulation Type: Addendum to Regular Notification
Standards and Specifications for Foods, Food Additives, Etc. under the Food Sanitation Act (Revision of agricultural chemical residue standards, final rule)
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
The proposed maximum residue limits (MRLs) for Tildipirosin notified in G/SPS/N/JPN/769 (dated 30 July 2020) were adopted and published on 16 November 2020. The specified MRLs are available as below:
Products Covered:
Regulation Type: Addendum to Regular Notification
Standards and Specifications for Foods, Food Additives, Etc. under the Food Sanitation Act (Revision of agricultural chemical residue standards, final rule)
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
The proposed maximum residue limits (MRLs) for Nanafrocin notified in G/SPS/N/JPN/768 (dated 30 July 2020) were adopted and published on 16 November 2020. The specified MRLs are available as below:
Products Covered:
Regulation Type: Addendum to Regular Notification
Standards and Specifications for Foods, Food Additives, Etc. under the Food Sanitation Act (Revision of agricultural chemical residue standards, final rule)
Distribution date: 08 January 2021 | Final date for Comment: 14 May 2025
The proposed maximum residue limits (MRLs) for Nanafrocin notified in G/SPS/N/JPN/768 (dated 30 July 2020) were adopted and published on 16 November 2020. The specified MRLs are available as below:
Products Covered:
Regulation Type: Addendum to Regular Notification
Submit your email ID to receive notifications about upcoming courses and events
